Filed revenue acceleration
Active · now 10.405226549519874%TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.
Copy the prompt to get recent events, historical reactions, and a short research brief.
Tell your AI:
Help me set up FinLab and analyze NYT The New York Times Company. Please read: https://finlab.finance/en/setup?stock=NYT
steady quality, premium valuation.
Quality is above average. Operating margin sits near the 68th percentile. TTM ROE is about 19.1%.
Valuation is expensive. TTM P/E is in the 83th percentile, above most peers.
Recent volatility is moderate. 60-day annualized volatility is near the 35th percentile. Average 20-day dollar volume is about $108.6M.
Signals are active now. Filed revenue acceleration currently holds; the tables below show what followed in this stock’s own history.
Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.
TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.
Daily TTM P/E is converted into an expanding own-history percentile, then grouped into five valuation regimes. Forward returns use adjusted prices over the next 240 trading days.
| PE percentile band | Sample days | 240-day avg return | Median | Win rate | Avg excess (vs index) |
|---|---|---|---|---|---|
| 0-20 | 554 | +26.2% | +29.1% | 90.6% | +12.9% |
| 20-40 You are here | 273 | +13.2% | +13.2% | 86.8% | -5.4% |
| 40-60 | 104 | -1.1% | +9% | 60.6% | -9.9% |
| 60-80 | 33 | -37.3% | -37.2% | 0% | -26.5% |
| 80-100 | 107 | -27.1% | -31.3% | 0.9% | -19.6% |
Quarterly EPS is aligned by SEC filing date before it is forward-filled to daily prices. The expanding percentile uses only information available up to each day.
Current TTM P/E is about 32.14, placing it in the 24.9 own-history percentile, inside the 20-40 bucket.
Each historical day is grouped by own-history P/E tercile and 60-day momentum direction, then tested for the next 120-trading-day adjusted return.
Currently in “Cheap (own-history bottom third) × 60-day momentum down”: across 340 historical days, 120-day forward avg gained 11.8%, win rate 81.8%, beat the market by 7.6%.
Days = trading days in this bucket; returns use adjusted prices, ex-costs. 60-day momentum: direction of this stock's price over the past 60 trading days.
Across 97,878 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.26%, a 58.3% positive-return rate, and +2.90 percentage points of average excess return versus the S&P 500.
Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).
Inactive signals still show the stock-specific historical forward-return distribution for context.
Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.
27 times historically; 60-day forward avg -0.61%, win rate 48.1%, beating the market by -3.99 pts on average.
The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.
24 times historically; 60-day forward avg +1.82%, win rate 39.1%, beating the market by -2.13 pts on average.
Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.
42 times historically; 60-day forward avg +5.36%, win rate 64.9%, beating the market by +1.94 pts on average.
This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.